Prevalence of factor V Leiden mutation in various populations

被引:0
|
作者
Herrmann, FH
Koesling, M
Schroder, W
Altman, R
Bonilla, RJ
Lopaciuk, S
PerezRequejo, JL
Singh, JR
机构
[1] HOSP NATL NINOS,SAN JOSE,COSTA RICA
[2] INST HEMATOL & BLOOD TRANSFUS,WARSAW,POLAND
[3] BANCO SANGRE DE CARABOBO,VALENCIA,VENEZUELA
[4] UNIV AMRITSAR,CTR GENET DISORDERS,AMRITSAR,PUNJAB,INDIA
关键词
frequency of APC resistance; factor V Leiden in Middle and South America; India;
D O I
10.1002/(SICI)1098-2272(1997)14:4<403::AID-GEPI5>3.0.CO;2-3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Resistance to activated protein C (APC) is the most common inherited risk factor for venous thrombosis. Most cases of APC resistance are caused by the point mutation nt 1691 G-A in factor V gene, referred to as factor V Leiden mutation. As initially shown in a Dutch population, this mutation has a carrier rate of 2.9%, the most frequent genetic disposition for thrombophilia and deep venous thrombosis. By large-scale epidemiological studies we have determined the prevalence of factor V Leiden mutation in populations from Poland (200), Argentina (215), Venezuela (126), Costa Pica (196), and India (150). The prevalences have been estimated for Poland (Warsaw) 5.0%, Argentina (Buenos Aires) 5.1%, Venezuela (Valencia) 1.6%, Costa Pica (San Jose) 2.0%, and India (Punjab) 1.3%. Based on worldwide distribution, it can be hypothesized that the factor V Leiden mutation has originated and accumulated in central European Caucasians and spread over the world by migration. (C) 1997 Wiiey-Liss, Inc.
引用
收藏
页码:403 / 411
页数:9
相关论文
共 50 条
  • [41] Cardiovascular implications of the factor V Leiden mutation
    Major, DA
    Sane, DC
    Herrington, DM
    AMERICAN HEART JOURNAL, 2000, 140 (02) : 189 - 195
  • [42] Factor v Leiden mutation in cerebrovascular disease
    Buyru, N
    Altinisik, J
    Somay, G
    Ulutin, T
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2005, 11 (03) : 339 - 342
  • [43] Absence of factor V Leiden mutation in Koreans
    Kim, YW
    Yoon, KY
    Park, S
    Shim, YS
    Cho, HI
    Park, SS
    THROMBOSIS RESEARCH, 1997, 86 (02) : 181 - 182
  • [44] RACIAL VARIATION WITH FACTOR V LEIDEN MUTATION
    Ortega, Rosa M. Michel
    Hughes, Amy
    Munoz, Javier
    Jinadu, Adepeju
    Hanbali, Amr
    Kuriakose, Philip
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S78 - S79
  • [45] Factor V Leiden mutation and completed stroke
    Catto, A
    Carter, A
    Grant, PJ
    STROKE, 1996, 27 (03) : 573 - 573
  • [46] Factor V Leiden mutation in the Argentinian population
    Hepner, M
    Roldan, A
    Pieroni, G
    Frontroth, JP
    Serviddio, RM
    Torres, AF
    Sciuccati, G
    Bonduel, M
    THROMBOSIS AND HAEMOSTASIS, 1999, 81 (06) : 989 - 989
  • [47] Prospective evaluation of the prevalence of factor V Leiden mutation in portal or hepatic vein thrombosis
    Denninger, MH
    Helley, D
    Valla, D
    Guillin, MC
    THROMBOSIS AND HAEMOSTASIS, 1997, 78 (04) : 1297 - 1298
  • [48] Prevalence of factor V mutation (Leiden) among patients with venous thrombosis and pulmonary embolism
    Hakimeh, N
    Daccache, J
    Germanos, M
    Kreideh, R
    Jurjus, A
    Karam, WG
    Almawi, W
    FASEB JOURNAL, 2001, 15 (04): : A383 - A383
  • [49] High prevalence of factor V Leiden mutation and 20210A prothrombin variant in Hungary
    Balogh, I
    Póka, R
    Pfliegler, G
    Dékány, M
    Boda, Z
    Muszbek, L
    THROMBOSIS AND HAEMOSTASIS, 1999, 81 (04) : 660 - 661
  • [50] Prevalence of the factor V Leiden mutation in human inflammatory bowel disease with different activity
    Nagy, Z
    Nagy, A
    Karádi, O
    Figler, M
    Rumi, G
    Süto, G
    Vincze, A
    Pár, A
    Mózsik, G
    JOURNAL OF PHYSIOLOGY-PARIS, 2001, 95 (1-6) : 483 - 487